Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for AMPH

Stock Name	Amphastar P
Ticker	AMPH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US03209R1032
LEI	54930055TH0ZLSAQMJ38

Show aggregate AMPH holdings

News associated with AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH) Given New $32.00 Price Target at Bank of America: Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its target price upped by Bank of America from $28.00 to $32.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock. Several other research firms also recently weighed in on AMPH. JPMorgan Chase & Co. reissued a “neutral” rating […] - 2025-08-27 02:52:54
Amphastar Pharmaceuticals (NASDAQ:AMPH) vs. Personalis (NASDAQ:PSNL) Financial Contrast: Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Amphastar Pharmaceuticals has a beta […] - 2025-08-20 02:55:13
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $25.00: Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target trimmed by Piper Sandler from $30.00 to $25.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares […] - 2025-08-11 03:08:44
The Math Shows IJS Can Go To $119: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:20
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Raised by Victory Capital Management Inc.: Victory Capital Management Inc. grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.9% in the first quarter, Holdings Channel.com reports. The fund owned 81,087 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,351,000 […] - 2025-07-29 04:20:54
New York State Common Retirement Fund Acquires 11,075 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): New York State Common Retirement Fund lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 15.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 81,565 shares of the company’s stock after purchasing an additional 11,075 shares during the quarter. New York State Common Retirement Fund’s holdings in Amphastar Pharmaceuticals were […] - 2025-07-24 04:40:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 493,214 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 85.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,231 shares of the company’s […] - 2025-06-06 04:42:49
Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company’s stock after purchasing an additional 11,929 shares during the period. Squarepoint Ops […] - 2025-06-03 05:38:56
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Nuveen Asset Management LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 54.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,665 shares of the company’s stock after selling 112,307 shares during the quarter. Nuveen Asset Management LLC’s holdings […] - 2025-06-02 05:04:53
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Two Sigma Investments LP: Two Sigma Investments LP lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 98,184 shares of the company’s stock after selling 614 shares during the quarter. Two Sigma Investments LP’s holdings in Amphastar Pharmaceuticals were worth $3,646,000 as of […] - 2025-05-29 05:14:54
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Two Sigma Advisers LP lessened its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 12.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,900 shares of the company’s stock after selling 12,400 shares during the period. Two Sigma Advisers LP’s holdings in Amphastar Pharmaceuticals were worth $3,189,000 as of its most […] - 2025-05-27 05:57:02
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company: The Manufacturers Life Insurance Company trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 21,257 shares of the company’s stock after selling 610 shares during the period. The Manufacturers Life Insurance Company’s holdings in Amphastar Pharmaceuticals were worth $789,000 as […] - 2025-05-15 04:45:07
Northern Trust Corp Purchases 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Northern Trust Corp raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 613,170 shares of the company’s stock after acquiring an additional 29,808 shares during the period. Northern Trust Corp’s holdings in Amphastar Pharmaceuticals were worth $22,767,000 as of its […] - 2025-05-13 05:28:51
Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 05:41:01
Analysts Forecast 23% Gains Ahead For IJT: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:57:34
First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 05:30:50
Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 05:12:50
Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 05:06:47
Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 04:38:49
American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 05:38:53
Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 04:40:47
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 05:41:08
AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 06:03:06
Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 05:54:49
Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 06:20:51
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler: Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 06:38:50

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AMPH holdings

Date	Number of AMPH Shares Held	Base Market Value of AMPH Shares	Local Market Value of AMPH Shares	Change in AMPH Shares Held	Change in AMPH Base Value	Current Price per AMPH Share Held	Previous Price per AMPH Share Held
2025-11-11 (Tuesday)	29,840	USD 810,454	USD 810,454	0	USD 31,033	USD 27.16	USD 26.12
2025-11-10 (Monday)	29,840	USD 779,421	USD 779,421	76	USD 64,192	USD 26.12	USD 24.03
2025-11-07 (Friday)	29,764	USD 715,229	USD 715,229	0	USD -5,953	USD 24.03	USD 24.23
2025-11-06 (Thursday)	29,764	USD 721,182	USD 721,182	76	USD -30,221	USD 24.23	USD 25.31
2025-11-05 (Wednesday)	29,688	USD 751,403	USD 751,403	0	USD 1,484	USD 25.31	USD 25.26
2025-11-04 (Tuesday)	29,688	USD 749,919	USD 749,919	77	USD 761	USD 25.26	USD 25.3
2025-11-03 (Monday)	29,611	USD 749,158	USD 749,158	0	USD -5,923	USD 25.3	USD 25.5
2025-10-31 (Friday)	29,611	USD 755,081	USD 755,081	0	USD 24,874	USD 25.5	USD 24.66
2025-10-30 (Thursday)	29,611	USD 730,207	USD 730,207	385	USD 21,769	USD 24.66	USD 24.24
2025-10-29 (Wednesday)	29,226	USD 708,438	USD 708,438	154	USD 5,477	USD 24.24	USD 24.18
2025-10-28 (Tuesday)	29,072	USD 702,961	USD 702,961	0	USD 4,070	USD 24.18	USD 24.04
2025-10-27 (Monday)	29,072	USD 698,891	USD 698,891	0	USD -13,954	USD 24.04	USD 24.52

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMPH by Blackrock for IE00BDZVHG35

Show aggregate share trades of AMPH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 76 26.830 23.812 24.114 USD 1,833 30.33
2025-11-06 BUY 76 25.530 24.150 24.288 USD 1,846 30.39
2025-11-04 BUY 77 25.400 24.926 24.973 USD 1,923 30.45
2025-10-30 BUY 385 24.800 24.070 24.143 USD 9,295 30.54
2025-10-29 BUY 154 24.240 24.705 24.658 USD 3,797 30.57
2025-10-22 SELL -308 24.520 24.830 24.799 USD -7,638 30.75 Profit of 1,834 on sale
2025-10-20 BUY 154 23.730 24.100 24.063 USD 3,706 30.83
2025-10-17 BUY 384 23.780 23.890 23.879 USD 9,170 30.87
2025-10-15 BUY 608 23.140 24.200 24.094 USD 14,649 30.92
2025-10-03 BUY 539 26.750 27.310 27.254 USD 14,690 30.99
2025-10-02 BUY 77 26.520 27.030 26.979 USD 2,077 31.01
2025-09-30 BUY 154 26.650 27.270 27.208 USD 4,190 31.06
2025-09-26 BUY 154 26.850 26.920 26.913 USD 4,145 31.12
2025-09-25 BUY 154 26.360 26.890 26.837 USD 4,133 31.15
2025-09-18 BUY 82 27.440 27.700 27.674 USD 2,269 31.17
2025-09-17 BUY 246 26.980 27.900 27.808 USD 6,841 31.19
2025-07-17 SELL -162 21.700 21.920 21.898 USD -3,547 31.42 Profit of 1,542 on sale
2025-07-11 SELL -656 21.660 22.140 22.092 USD -14,492 31.68 Profit of 6,289 on sale
2025-07-02 BUY 4,510 23.580 23.720 23.706 USD 106,914 31.92
2025-06-25 BUY 164 23.450 24.530 24.422 USD 4,005 32.16
2025-06-11 BUY 164 26.050 27.040 26.941 USD 4,418 32.67
2025-06-10 BUY 164 26.920 27.400 27.352 USD 4,486 32.71
2025-06-04 SELL -82 25.860 26.570 26.499 USD -2,173 32.92 Profit of 527 on sale
2025-04-23 BUY 82 23.560 24.690 24.577 USD 2,015 35.48
2025-04-10 SELL -656 23.520 25.010 24.861 USD -16,309 36.68 Profit of 7,751 on sale
2025-04-08 SELL -82 23.750 25.660 25.469 USD -2,088 36.96 Profit of 942 on sale
2025-04-07 SELL -81 25.000 25.950 25.855 USD -2,094 37.10 Profit of 910 on sale
2025-04-04 SELL -410 26.610 27.020 26.979 USD -11,061 37.22 Profit of 4,198 on sale
2025-04-01 BUY 1,116 28.290 29.270 29.172 USD 32,556 37.44
2025-03-31 SELL -237 28.990 29.180 29.161 USD -6,911 37.54 Profit of 1,987 on sale
2025-03-21 BUY 1,039 28.290 28.440 28.425 USD 29,534 38.26
2025-03-14 SELL -1,216 26.660 26.760 26.750 USD -32,528 39.02 Profit of 14,923 on sale
2025-03-07 SELL -152 28.810 29.370 29.314 USD -4,456 39.90 Profit of 1,609 on sale
2025-03-04 SELL -76 27.620 28.240 28.178 USD -2,142 40.47 Profit of 934 on sale
2025-02-25 BUY 152 31.990 32.560 32.503 USD 4,940 41.36
2025-02-19 SELL -76 31.210 31.450 31.426 USD -2,388 42.09 Profit of 810 on sale
2025-02-13 BUY 228 31.740 31.950 31.929 USD 7,280 42.97
2025-02-12 BUY 76 31.820 32.400 32.342 USD 2,458 43.19
2025-02-11 BUY 304 32.210 32.250 32.246 USD 9,803 43.42
2024-12-30 SELL -3,103 36.840 37.690 37.605 USD -116,688 47.26 Profit of 29,955 on sale
2024-11-18 SELL -1,260 44.160 44.860 44.790 USD -56,435 50.20 Profit of 6,817 on sale
2024-11-08 SELL -84 48.310 49.530 49.408 USD -4,150 50.51 Profit of 93 on sale
2024-10-21 SELL -84 50.820 51.420 51.360 USD -4,314 0.00 Loss of -4,314 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	76	26.830	23.812	24.114	USD 1,833	30.33
2025-11-06	BUY	76	25.530	24.150	24.288	USD 1,846	30.39
2025-11-04	BUY	77	25.400	24.926	24.973	USD 1,923	30.45
2025-10-30	BUY	385	24.800	24.070	24.143	USD 9,295	30.54
2025-10-29	BUY	154	24.240	24.705	24.658	USD 3,797	30.57
2025-10-22	SELL	-308	24.520	24.830	24.799	USD -7,638	30.75 Profit of 1,834 on sale
2025-10-20	BUY	154	23.730	24.100	24.063	USD 3,706	30.83
2025-10-17	BUY	384	23.780	23.890	23.879	USD 9,170	30.87
2025-10-15	BUY	608	23.140	24.200	24.094	USD 14,649	30.92
2025-10-03	BUY	539	26.750	27.310	27.254	USD 14,690	30.99
2025-10-02	BUY	77	26.520	27.030	26.979	USD 2,077	31.01
2025-09-30	BUY	154	26.650	27.270	27.208	USD 4,190	31.06
2025-09-26	BUY	154	26.850	26.920	26.913	USD 4,145	31.12
2025-09-25	BUY	154	26.360	26.890	26.837	USD 4,133	31.15
2025-09-18	BUY	82	27.440	27.700	27.674	USD 2,269	31.17
2025-09-17	BUY	246	26.980	27.900	27.808	USD 6,841	31.19
2025-07-17	SELL	-162	21.700	21.920	21.898	USD -3,547	31.42 Profit of 1,542 on sale
2025-07-11	SELL	-656	21.660	22.140	22.092	USD -14,492	31.68 Profit of 6,289 on sale
2025-07-02	BUY	4,510	23.580	23.720	23.706	USD 106,914	31.92
2025-06-25	BUY	164	23.450	24.530	24.422	USD 4,005	32.16
2025-06-11	BUY	164	26.050	27.040	26.941	USD 4,418	32.67
2025-06-10	BUY	164	26.920	27.400	27.352	USD 4,486	32.71
2025-06-04	SELL	-82	25.860	26.570	26.499	USD -2,173	32.92 Profit of 527 on sale
2025-04-23	BUY	82	23.560	24.690	24.577	USD 2,015	35.48
2025-04-10	SELL	-656	23.520	25.010	24.861	USD -16,309	36.68 Profit of 7,751 on sale
2025-04-08	SELL	-82	23.750	25.660	25.469	USD -2,088	36.96 Profit of 942 on sale
2025-04-07	SELL	-81	25.000	25.950	25.855	USD -2,094	37.10 Profit of 910 on sale
2025-04-04	SELL	-410	26.610	27.020	26.979	USD -11,061	37.22 Profit of 4,198 on sale
2025-04-01	BUY	1,116	28.290	29.270	29.172	USD 32,556	37.44
2025-03-31	SELL	-237	28.990	29.180	29.161	USD -6,911	37.54 Profit of 1,987 on sale
2025-03-21	BUY	1,039	28.290	28.440	28.425	USD 29,534	38.26
2025-03-14	SELL	-1,216	26.660	26.760	26.750	USD -32,528	39.02 Profit of 14,923 on sale
2025-03-07	SELL	-152	28.810	29.370	29.314	USD -4,456	39.90 Profit of 1,609 on sale
2025-03-04	SELL	-76	27.620	28.240	28.178	USD -2,142	40.47 Profit of 934 on sale
2025-02-25	BUY	152	31.990	32.560	32.503	USD 4,940	41.36
2025-02-19	SELL	-76	31.210	31.450	31.426	USD -2,388	42.09 Profit of 810 on sale
2025-02-13	BUY	228	31.740	31.950	31.929	USD 7,280	42.97
2025-02-12	BUY	76	31.820	32.400	32.342	USD 2,458	43.19
2025-02-11	BUY	304	32.210	32.250	32.246	USD 9,803	43.42
2024-12-30	SELL	-3,103	36.840	37.690	37.605	USD -116,688	47.26 Profit of 29,955 on sale
2024-11-18	SELL	-1,260	44.160	44.860	44.790	USD -56,435	50.20 Profit of 6,817 on sale
2024-11-08	SELL	-84	48.310	49.530	49.408	USD -4,150	50.51 Profit of 93 on sale
2024-10-21	SELL	-84	50.820	51.420	51.360	USD -4,314	0.00 Loss of -4,314 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMPH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	55,746	0	114,920	48.5%
2025-09-18	89,175	0	173,571	51.4%
2025-09-17	443,239	0	520,396	85.2%
2025-09-16	111,916	0	181,523	61.7%
2025-09-15	73,007	0	149,659	48.8%
2025-09-12	43,242	0	96,384	44.9%
2025-09-11	54,598	6	115,305	47.4%
2025-09-10	52,436	0	97,936	53.5%
2025-09-09	77,348	0	171,128	45.2%
2025-09-08	72,877	0	141,509	51.5%
2025-09-05	91,062	191	167,757	54.3%
2025-09-04	157,722	0	260,189	60.6%
2025-09-03	81,108	70	186,896	43.4%
2025-09-02	100,246	0	148,267	67.6%
2025-08-29	62,588	0	116,356	53.8%
2025-08-28	37,162	0	118,423	31.4%
2025-08-27	54,039	0	103,859	52.0%
2025-08-26	56,817	0	129,492	43.9%
2025-08-25	46,898	0	143,082	32.8%
2025-08-22	64,010	0	166,916	38.3%
2025-08-21	69,745	0	185,491	37.6%
2025-08-20	63,196	69	138,131	45.8%
2025-08-19	122,547	33	187,477	65.4%
2025-08-18	70,958	250	167,869	42.3%
2025-08-15	166,026	0	240,160	69.1%
2025-08-14	99,059	17	175,554	56.4%
2025-08-13	218,969	29,560	374,491	58.5%
2025-08-12	405,106	0	607,751	66.7%
2025-08-11	340,139	4,251	644,080	52.8%
2025-08-08	168,545	281	406,787	41.4%
2025-08-07	168,531	0	307,604	54.8%
2025-08-06	78,935	21	144,127	54.8%
2025-08-05	47,066	0	138,569	34.0%
2025-08-04	67,680	0	152,924	44.3%
2025-08-01	91,414	0	174,789	52.3%
2025-07-31	109,003	0	200,472	54.4%
2025-07-30	45,189	0	124,579	36.3%
2025-07-29	84,995	1,699	128,557	66.1%
2025-07-28	101,436	0	189,517	53.5%
2025-07-25	34,129	0	120,024	28.4%
2025-07-24	32,423	0	97,434	33.3%
2025-07-23	102,110	0	207,046	49.3%
2025-07-22	73,751	567	161,842	45.6%
2025-07-21	89,992	0	161,387	55.8%
2025-07-18	70,001	0	152,262	46.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE